Amazon (AMZN) trades at $231.90, ~17% below its $278.56 52-week high, with a market cap near $2.50T. The operating story is strengthening: FY2025 revenue rose 12% to $717B and operating income climbed 17% to $80B (11.2% margin), while Q1'26 revenue grew 17% to $181.5B with operating income up 30% to a record $23.9B (13.1% margin). The crown jewel is reaccelerating — AWS grew 28% to $37.6B in Q1'26, its fastest in 15 quarters, while advertising now runs above a $60B annualized rate. The bear case is the cash cost: TTM free cash flow has fallen ~95% to ~$1.2B as 2026 capex is guided to ~$200B, much of it AWS AI infrastructure (Trainium, Project Rainier, the $100B+ Anthropic compute commitment). Q1'26 EPS of $2.78 crushed the $1.64 estimate but was flattered by a $16.8B Anthropic mark-to-market gain. Sell-side is overwhelmingly constructive (Strong Buy consensus, ~$313 average PT). We rate BUY with Medium-High conviction; the AI capex pays off only if Trainium-led capacity monetizes on schedule.
| Company | Fwd P/E | EV/Rev | Rev Growth | Op. Margin |
|---|---|---|---|---|
| Amazon | ~27x | ~3.5x | +12-17% | ~13% |
| Microsoft | ~20x | ~8.5x | +18% | ~46% |
| Alphabet | ~27x | ~6x | +14% | ~33% |
| Walmart | ~33x | ~1x | +7% | ~4% |
| Scenario | Price Target | Assumptions | Probability |
|---|---|---|---|
| AWS Reacceleration + AI Monetization | $330 | AWS holds high-20s growth as Trainium/Anthropic capacity monetizes, ad revenue compounds past $70B run-rate, retail margins expand, and free cash flow recovers as the capex curve flattens. Re-rates toward the high end of consensus. | 30% |
| Steady Compounding, Capex Digestion | $300 | Revenue grows low-teens, AWS mid-20s, operating margin holds ~12-13%, but ~$200B capex keeps free cash flow depressed through 2026 before recovering in 2027. Lands near the ~$313 consensus mean. | 50% |
| AI Capex Overhang / Cloud Deceleration | $215 | AWS growth decelerates as capacity outpaces demand, Trainium monetization slips, free cash flow stays near zero into 2027, and the AI-capex digestion narrative compresses the multiple. Retests the low-$200s toward the $196 52-week low. | 20% |